Tested Applications
| Positive WB detected in | human brain tissue, MCF-7 cells, mouse liver tissue |
| Positive IP detected in | MCF-7 cells |
| Positive IHC detected in | human breast cancer tissue, human ovary tumor tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
55005-1-AP targets SETD1B in WB, IHC, IF/ICC, IP, ChIP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | SET domain containing 1B |
| Calculated Molecular Weight | 209 kDa |
| Observed Molecular Weight | 250-260 kDa, 450 kDa |
| GenBank Accession Number | NM_015048 |
| Gene Symbol | SETD1B |
| Gene ID (NCBI) | 23067 |
| RRID | AB_10858389 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UPS6 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SETD1B, also named as KMT2G. Set1B associates with a about 450 kDa complex that contains all five non-catalytic components of the Set1A complex, including CFP1, Rbbp5, Ash2, Wdr5, and Wdr82. The complex is a histone methyltransferase that produces trimethylated histone H3 at Lys4. Set1B is widely expressed, and localize to a largely non-overlapping set of euchromatic nuclear speckles, suggesting that Set1B bind to a unique set of target genes and thus make non-redundant contributions to the epigenetic control of chromatin structure and gene expression( PMID: 17355966). The antibody is specific to SETD1B and, in westernbloting experiments, two specific bands can be detected, about 250 kDa, 450 kDa respectively, in addition, a unknown band around 70 kDa. This antibody is a rabbit polyclonal antibody raised against a region of human SETD1B.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SETD1B antibody 55005-1-AP | Download protocol |
| IHC protocol for SETD1B antibody 55005-1-AP | Download protocol |
| IP protocol for SETD1B antibody 55005-1-AP | Download protocol |
| WB protocol for SETD1B antibody 55005-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SETD1B Polyclonal antibody (55005-1-AP) has 11 total citations across these journals: EMBO J, Cell Reports, Life Sciences, Molecular Cancer Research, International Journal of Molecular Sciences, International Immunopharmacology, Biogerontology, Biochimica et Biophysica Acta (Mol Cell Res), Neuroscience, American Journal of Cancer Research, and Histochemistry and Cell Biology. Research fields covered include epigenetics (H3K4me3 methylation, embryonic totipotency/pluripotency, development), neuroscience (ischemic stroke, ferroptosis/disulfidptosis, anesthesia-induced cognitive impairment), cancer (gliomas, liver cancer, HNSCC), and aging/ovarian function. Applications include WB, IHC, IF, and ChIP.
| Species | Application | Title |
|---|---|---|
EMBO J Histone methyltransferases MLL2 and SETD1A/B play distinct roles in H3K4me3 deposition during the transition from totipotency to pluripotency
| ||
Life Sci SETD1B promotes brain cell ferroptosis in ischemic stroke mice via increasing H3K4me3 enrichment on the Tfrc promoter | ||
Mol Cancer Res Downregulation of BASP1 promotes temozolomide resistance in gliomas via epigenetic activation of the FBXO32/NF-κB/MGMT axis | ||
Int Immunopharmacol NF-κB p65 and SETDB1 expedite lipopolysaccharide-induced intestinal inflammation in mice by inducing IRF7/NLR-dependent macrophage M1 polarization | ||
Int J Mol Sci (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells. |



























